Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • 40 Under 40
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Technology
June 23, 2014 12:00 AM

FDA: A new posture in digital health?

Darius Tahir
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    If there is any government agency viewed with suspicion and mistrust in Silicon Valley, it's the Food and Drug Administration. The agency's reputation among the valley's tech heads is a bad one—a stodgy, slow-moving agency officially concerned with high quality and safety. For a region that celebrates speed and, yes, even failure, no philosophy could be more opposed.

    That clash of philosophies has provided plenty of news fodder over the past week, and will surely lead to more Tuesday, when a lengthy list of the notable and the accomplished in both worlds will testify before the House Energy and Commerce Committee for a hearing on digital health.

    But despite the perceived split, the agency is—haltingly and incompletely—accommodating some of its California antagonists’ wishes. Not that you’d necessarily know it from the tone Silicon Valley uses. Balaji Srinivasan, a general partner at prominent Silicon Valley venture capital firm Andreessen Horowitz, often takes to Twitter to air his complaints about the agency, culminating recently in an eight-tweet series of examples needling the agency for its failure to move quickly, particularly for approving new sunscreens and anti-obesity pharmaceuticals.

    Industry analyst David Shaywitz says Srinivasan’s tone is shared by many, citing Bill Gurley, a venture capitalist who invested in OpenTable and Uber and who is interested in healthcare, but won’t pull the trigger on many investments: “He’s really looking hard for opportunities in this space, but he’d like one that doesn’t involve messy clinical studies or regulatory involvement.”

    “That’s pretty definitional for this space,” Shaywitz deadpanned. “Some folks in Silicon Valley say the healthcare system is so calcified that the only way (to go) is to completely go around the system and massively reinvent everything.”

    Shaywitz has some sympathy with that view, arguing that healthcare regulations often protect incumbents at the expense of new entrants because of a “risk aversion” from regulators.

    And yet, despite that risk aversion, FDA has been deregulating the field—both officially and unofficially.

    Officially, you can see the deregulation in actions like Friday’s draft guidance exempting medical-device data systems from regulation entirely. Three years ago, the systems were considered high-risk products. The official relaxing of regulations can best be seen in the recent draft framework regulating health IT, which foreswore FDA oversight over electronic health records, most clinical decision-support systems and many other fields.

    Unofficial deregulation activities are just as interesting. A January 2013 study in JAMA Dermatology found that readily available apps claiming to diagnose melanoma based on pictures of moles were often incredibly unreliable. And there are more. Last December, at the mHealth Summit, a questioner asked Jeff Shuren, the director of the Center for Devices and Radiological Health at FDA, whether the agency intended to do anything about questionable healthcare apps, noting that he could download one that claimed to cure stomach ulcers through phone vibrations.

    Shuren responded that, “We actually have been taking enforcement action … It doesn’t serve patients well if there are those kinds of technologies out there; it’s the modern-day version of snake oil.”

    But the FDA’s actions have been fairly limited. The FDA pursued action against an Indian firm, Biosense Technologies, because its uChek app claimed to measure several metrics, such as glucose and bloody urine, through urinalysis without the proper clearance. But that was after a trade journal, the Gray Sheet, pointed it out.

    And FDA hasn’t taken action, for example, against the numerous illegal prescription-drug sellers on Amazon.com, a Slate article has revealed.

    The most prominent Silicon Valley-style company to feel the sting of FDA oversight is probably 23andMe, which was the recipient of an FDA warning letter chastising the firm for marketing genetic tests linked to serious health conditions. Company founder Anne Wojcicki has said, that after receiving the letter, “I felt slapped in the face from out of left field.”

    Perhaps FDA’s inconsistency with digital health was what made it so surprising, but the FDA warning letter made it clear the firm and the agency had been in discussions since 2009 to get the firm the proper clearance. Nevertheless, 23andMe pressed on with a national TV campaign advertising its most serious diagnoses..

    Still, the firm has submitted to the FDA’s system. It announced last Friday that it would be pursuing clearance for a single test, linked to the inherited condition Bloom syndrome, calling it an “important step in our work” and that it would help “establish the parameters for future submissions.”

    That inconsistency and uncertainty is what drives critics of the agency, even when they acknowledge their approval of certain decisions. Dan Haley, a vice president of government and regulatory affairs with Athenahealth wrote in an e-mail that the medical-data-device-systems guidance illustrates a broader concern.

    “We like the direction,” he wrote, but “substantial revision … illustrates just how tenuous is the ‘certainty’ afforded by nonbinding guidance. And the ability to revise in a positive direction presupposes the opposite.”

    That’s why Haley supports legislation like the Preventing Regulatory Overreach to Enhance Care Technology Act, or PROTECT Act, and Sensible Oversight for Technology which Advances Regulatory Efficiency Act, or SOFTWARE Act, which he argues will codify future expectations for entrepreneurs, and that’s why all eyes will be on the Energy and Commerce Committee Tuesday, and in the future, as the center of efforts to make those changes.

    Follow Darius Tahir on Twitter: @dariustahir

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    doctor_patient_tablet_getty_i_i.jpg
    How AI may influence pain medication prescriptions
    Amir Dan Rubin
    Amazon's One Medical CEO to step down later this year
    Most Popular
    1
    Centene to lay off 2,000 workers
    2
    How health systems are battling price-gouging allegations
    3
    Senate advances bill to temporarily aid hospitals, health centers
    4
    Elevance, Blue Cross Louisiana halt $2.5B proposed deal
    5
    Tower Health to sell urgent care centers, close others
    Sponsored Content
    Digital Health Intelligence Newsletter: Sign up to receive a twice-weekly (T, F) morning newsletter featuring the latest reporting on technologies, trends, players and money fueling the rapid changes in how healthcare is developed, paid for and delivered.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • 40 Under 40
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing